Compound information
- Natural Products
- ZC1853866
- Molecular Formula
- C19H21NO5S
- Molecular Weight
- 375.114043772 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-(benzyloxycarbonylamino)-3-[(4-methoxyphenyl)methylsulfanyl]propanoic acid
- InChI
- InChI=1S/C19H21NO5S/c1-24-16-9-7-15(8-10-16)12-26-13-17(18(21)22)20-19(23)25-11-14-5-3-2-4-6-14/h2-10,17H,11-13H2,1H3,(H,20,23)(H,21,22)/t17-/m0/s1
- InChI Key
- ITIVJYICKMMKHE-KRWDZBQOSA-N
- SMILES
- COc1ccc(CSC[C@H](NC(=O)OCc2ccccc2)C(=O)O)cc1
- Source
- ZINC000002555061
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 84.86 Å2 | LogP | 3.17 |
LogS | -3.949 | LogD | 2.899 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.014 | Pgp substrate | 0.008 |
HIA | 0.963 | F20 % | 0.995 |
F30 % | 0.941 | Caco-2 | -5.842 |
MDCK | -4.769 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.324 | PPB | 93.811 |
VD | 0.339 | Fu | 1.546 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.094 | CYP1A2 substrate | 0.708 |
CYP2A6 substrate | 0.57 | CYP2B6 substrate | 0.626 |
CYP2C19 inhibitor | 0.307 | CYP2C19 substrate | 0.556 |
CYP2C8 substrate | 0.805 | CYP2C9 inhibitor | 0.494 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.134 |
CYP2D6 substrate | 0.623 | CYP2E1 substrate | 0.35 |
CYP3A4 inhibitor | 0.594 | CYP3A4 substrate | 0.699 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.821 | CL | 1.75 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.004 | Hepatotoxicity | 0.905 |
Mutagenicity | 0.014 | Rat Oral Acute Toxicity | 0.035 |
FDAMDD | 0.105 | Skin Sensitization | 0.355 |
Carcinogenicity | 0.057 | Eye Corrosion | 0.002 |
Eye Irritation | 0.01 | Respiratory Toxicity | 0.004 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.161 | IGC50 | 2.63 |
LC50FM | 4.105 | LC50DM | 4.98 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.481 | NR-AR-LBD | 0.308 |
NR-AhR | 0.011 | NR-Aromatase | 0.026 |
NR-ER | 0.433 | NR-ER-LBD | 0.345 |
NR-PPAR-gamma | 0.484 | SR-ARE | 0.049 |
SR-ATAD5 | 0.339 | SR-HSE | 0.095 |
SR-MMP | 0.008 | SR-p53 | 0.047 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.